This work identified major strategic moves for NYC's economic development, including a recommendation that NYC focus on higher-growth knowledge-based industries.
Additionally, this work identified a relationship between brainstem and leftward cortical asymmetry for processing rapid elements of speech in both normal and reading-impaired children.
This work identified self-optimizing controlled variables for the energy recovery bypass flowrates of the AFS, as well as a controller configuration for the steam extraction flowrate.
This work identified the best performing copolymers and, more significantly, emphasizes the importance of a systematic approach in designing appropriate copolymers for EOR polymer flooding applications.
This work identified splicing phenotypes associated with factors with described roles in other RNA-processing pathways, such as heterochromatic silencing and 3'end processing, highlighting the interconnected nature of RNA processing.
This work identified a target for anti-infective therapies based on disabling NO defenses, and demonstrated the utility of model-based approaches for exploring the complex, systems-level stress exerted by NO.
This work identified the thieno[3,2-c]pyridin-4-amine derivatives as novel BTK inhibitors and verified the value of thieno[3,2-c]pyridin-4-amine scaffold in drug design.
This work identified a microalgal PNPLA3 and proved it to be an important node in regulating lipid accumulation in microalgae, also demonstrating an efficient way to improve lipid productivity in microalgae by metabolic engineering.
This work identified a clear and significant difference between the cells can and core temperatures of up to 6 °C at discharge and 3 °C at charge, as well as axial temperature gradient.
This work identified a compound 53 with very good in vitro/in vivo efficacies, good DMPK properties together with better hERG tolerability and it is currently being profiled for the evaluation as a potential pre-clinical candidate.
This work identified ESA+CD44+CD24-/low ESA+CD44+CD24-/low as having greater tumorigenicity than cells lacking these markers.
